During the past decade, Eugene and Marilyn Glick Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eugene and Marilyn Glick Eye Institute" #1 collaborator was "Glaucoma Research Society of Canada" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Eugene and Marilyn Glick Eye Institute" are "Glaucoma" (1 trials), "Primary Open Angle Glaucoma" (1 trials) and "Primary Open-angle Glaucoma" (1 trials). Many other conditions were trialed in "Eugene and Marilyn Glick Eye Institute" in a lesser frequency.

Most popular intervention types in "Eugene and Marilyn Glick Eye Institute" are "Device" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ahmed FP7 Valve" (1 trials), "Baerveldt-350 Tube" (1 trials), "Glaucoma Surgery" (1 trials), "InnFocus MicroShunt" (1 trials) and "PRESERFLO® MicroShunt" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eugene and Marilyn Glick Eye Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Eugene and Marilyn Glick Eye Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Eugene and Marilyn Glick Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eugene and Marilyn Glick Eye Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".